NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 263 filers reported holding NEOGENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,159 | -32.3% | 21,395 | -11.6% | 0.00% | -50.0% |
| Q2 2023 | $388,910 | +15.1% | 24,201 | +245.8% | 0.00% | 0.0% |
| Q3 2021 | $338,000 | +7.0% | 6,998 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $316,000 | -62.2% | 6,998 | -59.6% | 0.00% | -75.0% |
| Q1 2021 | $836,000 | -76.4% | 17,328 | -73.7% | 0.00% | -73.3% |
| Q4 2020 | $3,548,000 | +29.2% | 65,899 | -11.5% | 0.02% | +15.4% |
| Q3 2020 | $2,746,000 | +13.1% | 74,439 | -5.1% | 0.01% | +8.3% |
| Q2 2020 | $2,429,000 | +8.0% | 78,399 | -3.8% | 0.01% | -14.3% |
| Q1 2020 | $2,249,000 | -13.3% | 81,474 | -8.2% | 0.01% | +7.7% |
| Q4 2019 | $2,595,000 | +3.1% | 88,729 | -32.6% | 0.01% | -7.1% |
| Q3 2019 | $2,518,000 | -13.7% | 131,671 | -1.0% | 0.01% | -12.5% |
| Q2 2019 | $2,917,000 | +331.5% | 132,946 | +302.6% | 0.02% | +300.0% |
| Q1 2019 | $676,000 | -16.4% | 33,019 | -48.5% | 0.00% | -20.0% |
| Q4 2018 | $809,000 | +6.0% | 64,134 | +29.0% | 0.01% | +25.0% |
| Q3 2018 | $763,000 | – | 49,729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,291,019 | $22,477 | 12.11% |
| Greenhouse Funds LLLP | 2,930,014 | $51,011,544 | 4.27% |
| First Light Asset Management, LLC | 2,698,958 | $46,988,859 | 4.23% |
| PERKINS CAPITAL MANAGEMENT INC | 197,000 | $3,430 | 3.23% |
| Altium Capital Management LP | 240,000 | $4,178,400 | 2.32% |
| FORMULA GROWTH LTD | 280,690 | $4,886,813 | 1.57% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 101,065 | $1,759,542 | 1.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,374,783 | $23,934,972 | 1.41% |
| EMERALD ADVISERS, LLC | 1,669,324 | $29,062,931 | 1.39% |
| Lisanti Capital Growth, LLC | 528,235 | $9,196,571 | 1.28% |